CURE Token | Launches Version 2 and Shows an Immediate Success

    CHICAGO, IL, September 18, 2021 /24-7PressRelease/ -- CURE Token, which was developed as a platform to support childhood cancer awareness and research successfully launches the next iteration of the project. This new version took off like a rocket, seeing over a 2 million dollar market cap in the first few hours after launch. New enhancements include a safer contract, better features for potential investors, and a sustainable foundation for exponential growth.

Jacob Beckley, the founder, long-time philanthropist, and innovator said, "CURE Token will change the world, CURE will become the household name alongside Bitcoin, Ethereum, and the like, known as the Token for Good." Since 2016, Jacob Beckley, has initiated several fundraisers and initiatives around childhood cancer awareness and research. He and his foundation have raised over one million dollars toward the fight against childhood cancer. CURE Token is the latest initiative in his quest to change the world.

CURE is much bigger than one cause. While today CURE is designed to support childhood cancer, in the near future, it will extend it's global reach to support all foundations and charities supporting other childhood diseases. The future from that point is extension beyond childhood diseases and cancer to other catastrophic and life threatening diseases.

September is childhood cancer awareness month. At the end of the month, CURE Token in collaboration with The Beckley Foundation will use the charitable fees collected to make a real difference in the lives of those affected by childhood cancers.

The Beckley Foundation
Our mission is to spread awareness for underfunded childhood cancers, fund breakthroughs in cancer research and support families afflicted by childhood cancers.

Our custodial nonprofit is The Beckley Foundation a 501c3 non-profit, philanthropic endeavor on the part of committed individuals from all walks of life bound together by the sincere desire to eradicate childhood cancer.

# # #